Venetoclax and Azacytidine Therapy in High-Risk Myelodysplastic Syndromes: A Retrospective Evaluation of a Real-World Experience. Latin-American MDS Group - Glam

Autor: Iastrebner, Marcelo *, Crisp, Renee Leonor *, Ovilla, Roberto *, Gomez-De Leon, Andres, Puente, Adriana Karola *, Barroso Duarte, Fernando *, Velloso, Elvira DRP *, Gusmao, Breno *, Varela, Ana *, Boada, Matilde *, Grille, Sofia
Zdroj: In Blood 15 November 2022 140 Supplement 1:12329-12330
Databáze: ScienceDirect